AI assistant
Sending…
RESMED INC — Director's Dealing 2017
Aug 24, 2017
30071_dirs_2017-08-24_74ec5d8b-6f21-44db-b4cf-359ebfd85d8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-08-18
Reporting Person: McHale Richard (President, RC Business)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 9.954 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| ResMed Stock Option Plan | $58.24 | 2022-11-19 | ResMed Common Stock (27846) | Direct |
Footnotes
F1: Includes unvested performance shares that had been certified as earned prior to becoming an officer.
F2: Represents date options first became exercisable. Options vest 1/3 annually each November 11 through 2018.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29